Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide PK/PD in Gestational Diabetes
NCT05482789Phase 4Recruiting
- Start
- Apr 2023
- Primary completion
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in gestational diabetes mellitus (GDM). Started Apr 2023; status: recruiting.
02
Drugs
exenatide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT05482789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05482789.